advertisement
Schmetterer L 32
Showing records 1 to 25 | Display all abstracts from Schmetterer L90077 Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Kadziauskienė A
Journal of Glaucoma 2020; 29: 648-655
90450 Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
G Konstas A
Expert Opinion on Drug Safety 2020; 19: 1445-1460
90112 Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Chua J
Ophthalmology. Glaucoma 2020; 3: 314-326
90077 Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Chua J
Journal of Glaucoma 2020; 29: 648-655
90112 Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Tan B
Ophthalmology. Glaucoma 2020; 3: 314-326
90450 Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Schmetterer L; Costa VP
Expert Opinion on Drug Safety 2020; 19: 1445-1460
90077 Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Baskaran M
Journal of Glaucoma 2020; 29: 648-655
90112 Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Ke M
Ophthalmology. Glaucoma 2020; 3: 314-326
90450 Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Holló G
Expert Opinion on Drug Safety 2020; 19: 1445-1460
90112 Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Schwarzhans F
Ophthalmology. Glaucoma 2020; 3: 314-326
90077 Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Yow AP; Tan B
Journal of Glaucoma 2020; 29: 648-655
90450 Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Katsanos A
Expert Opinion on Drug Safety 2020; 19: 1445-1460
90112 Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Vass C
Ophthalmology. Glaucoma 2020; 3: 314-326
90077 Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Sng C
Journal of Glaucoma 2020; 29: 648-655
90112 Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Wong D
Ophthalmology. Glaucoma 2020; 3: 314-326
90450 Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Denis P
Expert Opinion on Drug Safety 2020; 19: 1445-1460
90112 Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Nongpiur ME
Ophthalmology. Glaucoma 2020; 3: 314-326
90077 Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Ašoklis R
Journal of Glaucoma 2020; 29: 648-655
90450 Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Quaranta L
Expert Opinion on Drug Safety 2020; 19: 1445-1460
90112 Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Wei Chua MC
Ophthalmology. Glaucoma 2020; 3: 314-326
90450 Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Irkec M
Expert Opinion on Drug Safety 2020; 19: 1445-1460
90077 Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Lesinskas E
Journal of Glaucoma 2020; 29: 648-655
90112 Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Yao X
Ophthalmology. Glaucoma 2020; 3: 314-326
90450 Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Castejón MA
Expert Opinion on Drug Safety 2020; 19: 1445-1460
90077 Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Crowston J
Journal of Glaucoma 2020; 29: 648-655
